Stock search

Ticker or company name

Becton Dickinson

BDX · NYSE · Health Care

$216,47Down −1,56 (−0,72%)today

Quotes delayed up to 15 min. Updated 16 Nov, 16:00 New York time

Market cap
$59,4 bn
Div. yield
1,6%
Year to date
+42,9%
52 weeks: $140,11$219,78

Ratio score

38/100
Ratio would not consider buying

based on 8 metrics as of 16.11.2026 ·

Verdict by our methodology based on current metrics. Not an investment recommendation.

Key metrics

2 ✓ · 2 — · 4 ✕ · 2 n/a · hover over a row or tap it to see the trend

All metrics

MetricValue5-year medianIndustry median
P/E TTM51,841,525,1
Forward P/E14,9—16,2
PEG−27,1—2,2
P/S2,93,42,2
EV/EBITDA16,418,517,3
P/FCF21,5—19,5
P/B2,42,63,4

Industry median — across 33 profitable companies in “Health Care” in Ratio. Revenue and EPS forecasts for future years and the number of employees are in the paid data plan.

Price chart

Compare with

Choose a stock

Closing prices adjusted for splits and dividends. The S&P 500 index and the intraday chart come later.

Analysts

Ratings, 21 analysts

Buy
12
Hold
8
Sell
1

Beat the EPS forecast in 4 of the last 4 quarters

QuarterEstimateActualSurprise
Q4 20264,114,15Up +1,0%
Q3 20263,173,23Up +1,8%
Q2 20262,802,90Up +3,5%
Q1 20262,842,91Up +2,4%

Price targets and yearly revenue and EPS forecasts are in the paid data plan. These are analysts' opinions, not our verdict.

Financials in charts

MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23
Revenue4,98 bn4,71 bn5,25 bn5,89 bn5,51 bn5,27 bn5,17 bn5,44 bn4,99 bn5,05 bn4,71 bn5,09 bn
EPS1,37−1,111,341,722,001,071,041,371,681,850,960,34
Margin7,6%−6,6%7,3%8,4%10,4%5,8%5,9%7,4%9,8%10,6%6,0%2,1%
FCF633 m——1,00 bn1,05 bn35,0 m588 m882 m1,12 bn380 m739 m1,03 bn

From SEC reports. TTM is the sum of 4 quarters; a year is TTM at the end of the calendar year. Forecast bars are in the paid data plan.

Owners

Ownership structure and major holders (13F filings) are in the paid data plan. They are not part of the score or the traffic light.

Insider trades over 12 months

Over 12 months: no purchases, sales $3,38 m.

NameAmountSharesPrice
polen thomas e jr5 Nov 2026 · sale$628 5302 993$210,00
feld michael26 Oct 2026 · sale$15 05876$198,13
feld michael28 Sep 2026 · sale$13 96176$183,70
feld michael26 Aug 2026 · sale$31 101165$188,49
polen thomas e jr13 Aug 2026 · sale$768 1204 152$185,00
goette roland11 Aug 2026 · sale$440 8882 438$180,84
feld michael27 Jul 2026 · sale$11 78575$157,13
feld michael26 Jun 2026 · sale$11 46075$152,80
garrison michael david24 Jun 2026 · sale$160 2261 100$145,66
garrison michael david10 Jun 2026 · sale$166 6281 100$151,48
polen thomas e jr1 Jun 2026 · sale$404 5112 764$146,35
feld michael26 May 2026 · sale$11 05175$147,35
feld michael27 Apr 2026 · sale$11 24474$151,94
feld michael26 Mar 2026 · sale$11 76275$156,83
feld michael26 Feb 2026 · sale$13 63875$181,84

SEC Form 4. Titles and trading plans are not in the data. They are not part of the score or the traffic light.

About the company

Industry
Health Care
Exchange
NYSE
Country
US
IPO date
25 Sep 1963
Website
www.bd.com

Company description, revenue by segment and region, and the CEO will come later.

Next report
date not announced

An AI summary of the earnings call will come later.

Peers

CompanyPrice
EWEdwards Lifesciences$107,1156would watch60,3+13,4%15,2%
IDXXIdexx Laboratories$700,6583would consider47,2+11,9%25,4%
BSXBoston Scientific$43,6983would consider18,4+8,9%16,6%
HUMHumana$461,2561would watch44,0+22,0%0,8%
CAHCardinal Health$283,85no score35,7——
Compare with peers

Ratio — a score by our methodology, not an investment recommendation.